MRNA vs VHI · rev $145.0M vs rev $2.10B
Moderna Inc (MRNA) versus Valhi Inc (VHI) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Valhi Inc (VHI) is a chemicals company listed on NYSE.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported VHI revenue for 2024-12-31 was $2.10B. Net income was $161.3M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. VHI currently screens at market cap $399.3M.
MRNA currently screens at market cap $24.52B. VHI currently screens at market cap $399.3M.
Not investment advice. Open the MRNA and VHI stock pages for the full models.
Not investment advice.